Eagle Health Investments LP: ILLUMINA INC (ILMN): Quarterly 13F Position History
As of Q1 2026, Eagle Health Investments LP reported 187,413 shares of ILLUMINA INC (ILMN), worth $23.1M and representing 4.8% of its 13F equity book. Quarter-over-quarter share count change: 43,748 (-18.9%) . The position first appeared in Q4 2020 and has been disclosed across 22 13F-HR filings in Pactolio's tracked window.
- 187,413Shares Held (Latest Filing)
- $23.1MReported Market Value (Latest Filing)
- 4.8%Portfolio Weight (% of 13F Equity Book)
- 43,748Quarter-over-Quarter Share Change
- -$7.2MQuarter-over-Quarter Value Change
- 387,354Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 22 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 187,413 | 43,748 | -18.9% | $23.1M | 4.8% | $123.3 |
| Q4 2025 | 231,161 | 91,100 | -28.3% | $30.3M | 6.7% | $131.2 |
| Q3 2025 | 322,261 | 21,100 | -6.1% | $30.6M | 8.0% | $95.0 |
| Q2 2025 | 343,361 | 0 | — | $32.8M | 8.1% | $95.4 |
| Q1 2025 | 343,361 | 0 | — | $27.2M | 7.1% | $79.3 |
| Q4 2024 | 343,361 | 43,993 | -11.4% | $45.9M | 11.2% | $133.6 |
| Q3 2024 | 387,354 | +68,600 | +21.5% | $50.5M | 9.7% | $130.4 |
| Q2 2024 | 318,754 | 0 | — | $33.3M | 5.9% | $104.4 |
| Q1 2024 | 318,754 | 0 | — | $43.8M | 8.3% | $137.3 |
| Q4 2023 | 318,754 | +200,852 | +170.4% | $44.4M | 9.0% | $139.2 |
| Q3 2023 | 117,902 | 47,398 | -28.7% | $16.2M | 3.6% | $137.3 |
| Q2 2023 | 165,300 | 42,172 | -20.3% | $31.0M | 5.8% | $187.5 |
| Q1 2023 | 207,472 | +69,558 | +50.4% | $48.2M | 9.4% | $232.6 |
| Q4 2022 | 137,914 | 75,287 | -35.3% | $27.9M | 6.4% | $202.2 |
| Q3 2022 | 213,201 | +94,093 | +79.0% | $40.7M | 9.3% | $190.8 |
| Q2 2022 | 119,108 | +119,108 | — | $22.0M | 5.1% | $184.4 |
| Q1 2022 | 0 | 0 | — | $0 | 0.0% | — |
| Q4 2021 | 0 | 0 | — | $0 | 0.0% | — |
| Q3 2021 | 0 | 0 | — | $0 | 0.0% | — |
| Q2 2021 | 0 | 0 | — | $0 | 0.0% | — |
| Q1 2021 | 0 | 15,700 | -100.0% | $0 | 0.0% | — |
| Q4 2020 | 15,700 | — | — | $5.8M | 3.7% | $370.0 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Eagle Health Investments LP first disclose a ILMN position in 13F-HR filings?
Eagle Health Investments LP first reported ILLUMINA INC (ILMN) on its 13F-HR filing for the period ending 2020-12-31 (Q4 2020). The position has appeared on 22 reported quarters within Pactolio's tracked window.
What was Eagle Health Investments LP's most recent quarter-over-quarter share-count change in ILMN?
Between Q4 2025 and Q1 2026, Eagle Health Investments LP reduced its ILMN position by 43,748 shares (-18.9%), leaving 187,413 shares at a market value of $23.1M.
Does the implied price-per-share represent Eagle Health Investments LP's cost basis in ILMN?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.